AGILON HEALTH INC (AGL) Stock Balance Sheet
NYSE:AGL • US00857U1079
Current stock price
26.21 USD
-0.11 (-0.42%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 173.71M | 188.23M | 107.57M | 497.10M | 1.04B | |||
| Marketable Securities | 111.43M | 211.74M | 380.77M | 411.90M | N/A | |||
| Receivables | 673.79M | 1.02B | 942.46M | 497.60M | 293.40M | |||
| Other Current Assets | 137.76M | 40.77M | 49.27M | 44.70M | 33.80M | |||
| Total Current Assets | 1.10B | 1.46B | 1.48B | 1.45B | 1.37B | |||
| Non-Current Assets | ||||||||
| PPE Net | 28.96M | 36.95M | 40.99M | 33.10M | 20.90M | |||
| Investments And Advances | 59.79M | 61.76M | 44.75M | 17.40M | 6.70M | |||
| Goodwill | 0.00 | 24.13M | 24.13M | 41.50M | 41.50M | |||
| Intangibles | 65.72M | 72.77M | 63.77M | 67.70M | 55.40M | |||
| Other Non-Current Assets | 20.12M | 80.60M | 87.15M | 86.50M | 94.50M | |||
| Total Non-Current Assets | 174.59M | 276.21M | 260.79M | 246.20M | 219.10M | |||
| TOTAL ASSETS | 1.27B | 1.73B | 1.74B | 1.70B | 1.59B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 19.24M | N/A | 6.25M | 5.00M | 5.00M | |||
| Accrued Expenses | N/A | 2.46M | 2.85M | N/A | N/A | |||
| Accounts Payable | 127.48M | 217.88M | 230.34M | 183.40M | 112.90M | |||
| Other Current Liabilities | 929.77M | 931.66M | 737.72M | 346.70M | 239.00M | |||
| Total Current Liabilities | 1.08B | 1.15B | 977.16M | 535.10M | 357.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 15.75M | 34.90M | 32.31M | 38.50M | 43.40M | |||
| Other Non-Current Liabilities | 52.32M | 76.12M | 70.38M | 83.30M | 94.30M | |||
| Total Non-Current Liabilities | 68.07M | 111.03M | 101.87M | 121.10M | 137.40M | |||
| TOTAL LIABILITIES | 1.14B | 1.26B | 1.08B | 656.20M | 494.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.98B | -1.59B | -1.33B | -1.06B | -957.70M | |||
| Additional Paid In Capital | 2.10B | 2.05B | 1.99B | 2.11B | 2.05B | |||
| Minority Interest | N/A | 0.00 | -818.00K | -600.00K | -300.00K | |||
| Common Shares | 4.15M | 4.12M | 4.06M | 4.10M | 4.00M | |||
| Other Shareholders' Equity | 916.00K | -88.00K | -2.30M | -5.60M | N/A | |||
| Shares Outstanding | 16.59M | 16.49M | 16.26M | 16.50M | 16.00M | |||
| Tangible Book Value per Share | 3.68 | 22.69 | 35.31 | 56.50 | 62.17 | |||
| Total Shareholders' Equity | 126.73M | 470.95M | 661.84M | 1.04B | 1.09B | |||
| TOTAL LIABILITIES AND EQUITY | 1.27B | 1.73B | 1.74B | 1.70B | 1.59B | |||
| Statistics | ||||||||
| Debt/Equity | 0.12 | 0.07 | 0.05 | 0.04 | 0.04 | |||
| Current Ratio | 1.02 | 1.27 | 1.51 | 2.71 | 3.83 | |||
| Return On Assets (ROA) | -30.78% | -15.00% | -15.08% | -6.28% | -25.63% | |||
| Return On Equity (ROE) | -308.79% | -55.24% | -39.68% | -10.24% | -37.23% | |||
All data in USD , ROIC based on taxRate of 0.21